PDF-CLINICAL PERSPECTIVES New oral anticoagulants a practi

Tran J Joseph L Young S McRae J Curnow H Nandurkar P Wood and C McLintock Haemostasis Thrombosis Unit The Alfred Hospital Haematology Department Melbourne University Melbourne Victoria Haematology Department St Vincents Hospital Haemophilia Treatmen. Eliot Williams, MD PhD. Division of Hematology & Medical Oncology. Nothing to disclose. History of anticoagulant therapy. 1910 1920 1930 1940 1950 1960 1970 1980 1990 2000 2010. Northlakes. Community Clinic. Minong, WI. Novel Anticoagulants:. Who Needs an INR Anymore?. Apixaban. (. Eliquis. ):. Approved in 2014. Rivaroxaban. (. Xarelto. ):. Approved in 2011. Dabigatran. (. R2 Patcharee Seesongsom. R2 . Sirada. . Phojai. Advisor AJ . T. a. chawan. . J. iratiwanon. Scope. Overview. Introduction of NOACs. Rivaroxaban. ( . Xarelto. ). Dabigatran. ( . Pradaxa. ). Fawaz Altuwaijri. ACEM trainee. Introduction. Characteristics . of novel . anticoagulants. Laboratory Testing. Reversal in the bleeding patient. Introduction. Prevalence . atrial fibrillation. . 3.03 million in 2005. Babak Moini, MD. Veterans Affairs Hospital. Noon Lecture . S. eries. Acknowledgment: . Some of the slides were borrowed from Amanda Miller Phar.D. . Case1. 68 male with . hx. of DM, CHF and prior ischemic CVA admitted for new . Adriana Clark, DDS. 1. Agenda. Introduction. Oral Cancer Facts. Oral Cancer Screening. Mucosa lesion assessment.. - Patient History. - Visual Screening Examination. . Extraoral. and Intraoral (Inspection-Palpation). Christopher Granger, . MD. Sean Pokorney, MD. . Disclosure (Dr. Granger). Research contracts: AstraZeneca, Daiichi, Bayer, Novartis, GSK, Sanofi-Aventis, BMS, Pfizer, Medtronic Foundation, The Medicines Company, and Boehringer . Lanae Fox, . PharmD. , BCPS. I have no financial disclosures to report. Objectives. Understand the relative benefits and limitations of oral anticoagulant options. Recognize strategies for optimal use of oral anticoagulants and minimize risk of bleeding with these agents. 1. . . The increased risk of preterm birth after cervical trauma is well known. 2,3. , however the efficacy of a transabdominal cerclage when inserted into a cervix with previous trauma is unknown. . This presentation is based on the . December 2013. AHRQ WebM&M Spotlight Case. See the full article at . http://webmm.ahrq.gov. . CME credit is available. Commentary by: . Margaret . C. Fang. , MD, MPH, University of California, San Francisco. , RN. Evy Warmbier, MSN, RN, CNE. Objectives. To Identify the Basic Hematological Components. To Understand the Clotting Cascade. To Relate the Fibrinolytic Systems Regarding Medication Administration. existing clots from growing larger. Although anticoagulants are sometimes called blood thinners , they do not actually thin the blood. The job of anticoagulants is to promote the smooth flow of bloo Antibiotic use in dental practice Oral Patol Oral Cir Bucal 200 Antibiotic use in dental practice Med Oral Patol Oral Cir Bucal 200 Valencia Correspondence: Dr. Rafael Geno J . Merli. , MD, MACP, FSVM, FHM. Professor Medicine & Surgery. Sidney Kimmel Medical College. Thomas Jefferson University Hospitals. Disclosures. Geno J . Merli. , MD. Research Grant BMS-Pfizer: ADIOS study completed 12/2019 Presented ACC Meeting 3/2019.